Andy Bowler and Alex Denoon mentioned on the Law Society Gazette

Our partners commented on the new Medicine and Medical devices Bill and the increase of judicial proceedings around biosimilars


The latest edition of the Law Society Gazette includes Andrew Bowler and Alex Denoon’s opinions on the most significant developments affecting the pharmaceutical sector and related ligation trends. The two Bristows partners, respectively focusing on patent litigation and life sciences regulatory, were quoted in an article on Brexit, vaccine development, and the pharmaceutical regulatory landscape.

You can read the full issue on the Law Society Gazette website.

Andrew Bowler


Alex Denoon


Related Articles